Comparative efficacy of calcipotriol (MC903) cream and betamethasone 17-valerate cream in the treatment of chronic plaque psoriasis. A randomized, double-blind, parallel group multicentre study

Severe Psoriasis – Oral Therapy with a New Retinoid

1978 • 2,660 citations

Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgaris

1991 • 353 citations

Improvement of psoriasis by a topical vitamin D3 analogue (MC 903) in a double-blind study

1988 • 209 citations

Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgaris

1992 • 197 citations

Treatment of Psoriasis by the Topical Application of the Novel Cholecalciferol Analogue Calcipotriol (MC 903)

1989 • 184 citations

Simultaneous assessment of inflammation and epidermal proliferation in psoriatic plaques during long-term treatment with the vitamin D3 analogue MC903: modulations and interrelations

1991 • 70 citations

High-dose topical calcipotriol in the treatment of extensive psoriasis vulgaris

1993 • 60 citations

Long-term efficacy and tolerability of topical calcipotriol in psoriasis. Results of an open study.

1991 • 55 citations

DNA content and Ks8.12 binding of the psoriatic lesion during treatment with the vitamin D3 nalogue MC903 and betamethasone

1990 • 46 citations

Treatment of psoriasis vulgaris with topical calcipotriol has no short/term effect on calcium or bone metabolism. A randomized, double/blind, placebo/controlled study.

1993 • 42 citations